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Raman spectroscopy monitoring
of the cellular activities of a tissue-engineered
ex vivo produced oral mucosal equivalent
Wen-Liang Lo,a,b Jian-Yun Lai,c Stephen E. Feinberg,d Kenji Izumi,e
Shou-Yen Kao,a,b Che-Shoa Chang,a,b Alan Linf and Huihua Kenny Chiangc∗
To ensure quality control and assurance in tissue engineering, noninvasive, real-time and aseptic evaluation of cell-based devices
is required before product release. In this study, Raman spectroscopy was applied to monitor the cellular activities of an oral
mucosa equivalent (EVPOME) produced ex vivo from cultured autogenous oral keratinocytes and acellular dermis – AlloDerm.
Raman spectra showed a positive correlation of the peak area ratio of amide I (1655 cm−1)/phenylalanine (1004 cm−1) with a
negative linear regression (R2 > 0.95) according to the number of cultured days, especially on the 14thand 21st day. This work
demonstrates the successful application of Raman spectroscopy for quantitatively monitoring and evaluating the maturity of
EVPOME. Copyright c© 2010 John Wiley & Sons, Ltd.
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Introduction
In Taiwan, oral cancer has the sixth highest mortality rate among
all cancers. The 5-year survival rate for oral cancer patients in
Taiwan is about 50%.[1] The treatment regimen relies mainly on
surgery, with chemotherapy and radiotherapy, usually used as
adjunct therapies. Currently, the repair of small to moderate soft
tissue defects after surgery uses either split-thickness skin grafts
(STSGs) or full-thickness skin grafts (FTSGs) from the patient.
STSG is used for covering the raw surface of the wound. The
most common morbidity is scar contracture and/or infection
over the donor site. Ex vivo produced oral mucosa equivalent
(EVPOME) is ‘surgeon friendly’ in its handling characteristics and
has been successfully developed as a bi-layered oral mucosa
substitute by growing human oral keratinocytes on an acellular
cadaveric human dermal matrix, AlloDerm (LifeCell Corporation,
Branchburg, NJ). EVPOME has just completed a Federal Drug
Administration (FDA) approved human clinical trial as a proof
of concept for its use in periodontal treatment.[2 – 4] However,
according to the regulatory guidelines of the FDA,[5] the fabricated
EVPOME should be monitored before being transplanted back into
the patient. Only a few techniques are capable of noninvasively
determining the viability, metabolic activity and morphology of
the cellular components of tissue-engineered cell-based devices
during the manufacturing process. The techniques need to be
administered with transparent or semitransparent scaffolds such
as gels,[6] with the introduction of gene-engineered exogenous
fluorophores[7] or with complicated isotope nuclear magnetic
resonance spectroscopy.[8,9] However, these techniques do not
monitor the growth pattern of the EVPOME matrix in real time
under FDA regulations. Gel scaffolds cannot be sterilized to prevent
occult infections, and gene-engineered fluorophores and isotopes
are prohibited from being used in cell-based products applied to
humans.
An increasing number of clinical studies have demonstrated the
noninvasive capability of Raman spectroscopy as a diagnostic tool
in clinical applications.[10 – 12] Here we use Raman spectroscopy to
measure the characteristics of EVPOME during growth and fulfill
the needs of noninvasive, real-time monitoring of the biomaterial
during fabrication.
Experimental
Procurement of human oral mucosa
Keratinized oral mucosa was obtained from patients undergoing
tooth extraction and/or minor dento-alveolar surgery. The protocol
for harvesting human oral mucosal tissue was approved by
the Taipei Veterans General Hospital Internal Review Board. All
individuals signed informed consent forms before the tissue
samples were procured.
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Cell cultures
Primary human oral mucosal keratinocytes were obtained from
keratinized oral mucosa (alveolar ridge, tuberosity, etc.) and
cultured as described elsewhere.[4]
Cells were cultured in a chemically defined system, de-
void of animal-derived products (EpiLife supplemented with
growth factors (Cascade Biologics, Portland, OR, USA)), with a
calcium concentration of 0.06 mM and supplemented with Fun-
gizone (0.375 µg/ml; GIBCO, Grand Island, NY) and gentamicin
(0.025 mg/ml; GIBCO). Cells were maintained at 37 ◦C in a 5% CO2
incubator. At a density of 80–90% confluence, cells were treated
with 0.025% trypsin/ethylenediaminetetraacetic acid (EDTA) (Cas-
cade Biologics) and then neutralized with 0.0125% Defined Trypsin
Inhibitor (Cascade Biologics). These detached oral keratinocytes
were cryopreserved in liquid nitrogen for the cell bank or were
passaged for EVPOME fabrications. To get the reference Raman
spectra of the cultured oral keratinocytes, we cultivated the oral
keratinocytes on a sterilized silicon chip. The keratinocytes were
counted and seeded at the same time and kept under the same
growth conditions.
EVPOME fabrications
When the epithelial cells grown in culture flasks reached 80–90%
confluence, we prepared the EVPOME.
Day 0: Cut the AlloDerm (LifeCell Corporation) to the size of
each well of the 48-well cell culture plate (Corning, Lowell, MA,
USA) under sterile conditions. Place the AlloDerm pieces into the
60 × 15 mm polystyrene tissue culture dish and rehydrate three
times with D-PBS (without Ca2+ and Mg2+). Pretreat the hydrated
AlloDerm with human type IV collagen and store overnight at 4 ◦C.
Day 1: Trypsinize and neutralize the cell suspension with the
procedure mentioned above. Centrifuge cell suspension for 5 min
at 24 ◦C and 1000 rpm. Re-suspend cell pellet in 1.2 mM Ca2+
EpiLife growth medium. Seed 150 000 keratinocytes per well.
Day 1–4: Change medium daily with the EVPOME submerged.
Day 4: Transfer the EVPOME to the air/liquid interface using the
6-well/Transwell plate with inserts (Organogenesis, Canton, MA).
Day 5–21: Feed every other day with 1.2 mM Ca2+ growth
medium. On day 1, 7, 14 and 21, EVPOMEs are tested with
immunohistochemistry examinations.
Raman spectroscopic measurements
Raman spectra were measured from human normal oral mucosa
and the corresponding EVPOME with a confocal microscopic
Raman spectroscopy system (LabRAM HR800, Jobin Yvon, Cedex,
France). The system consists of an 80-cm focal length spectrometer
(Jobin Yvon), a confocal microscope (BX-41, Olympus, Tokyo,
Japan), a 632.8-nm, 18-mW He–Ne laser, a 1800 g/mm grating and
a liquid-nitrogen-cooled CCD detector with 1024 × 256 pixels.
Data analysis
Each Raman spectrum was obtained from the average of five
Raman measurements with 120-s integration time from the sample
to achieve a good signal-to noise-ratio. The five measurement
locations were randomly selected from each natural human oral
mucosa biopsy on day 1, 7, 14 and 21 during the EVPOME growth.
Before the band area calculations, the original Raman spectrum
was subtracted by the linear baseline of each band envelope. The
procedures used to obtain the peak ratios were similar to those
used by Tarnowski et al.[13] in their analysis of the mineralization
of the developing mouse calvarias by Raman spectroscopy.
Results and Discussion
Raman spectroscopy of the natural human oral mucosa biopsy
The Raman spectrum of the normal human keratinized oral mucosa
is shown in Fig. 1, with weak the amide I at 1650 cm−1, the
strong CH2 deformation at 1440 cm−1, broad peaks in the amide
III 1200–1350 cm−1, broad C–OH peak at 1080 cm−1 and the
sharp phenylalanine peak at 1004 cm−1. All these peaks indicate
contributions from proteins and lipids. To measure the Raman
spectra of different layers of the epithelium, we sliced the normal
oral mucosa tissues into three groups, with sections between
0–50, 50–100 and 100–150 µm. We found that the Raman peak
intensities of amide I, C–H, amide III and C–OH decreased from
100–150 to 0–50 µm slices as the oral keratinocytes matured.
This phenomenon demonstrates the relationship between the
maturities of the keratinized oral mucosa and the different
components between the connective tissue and epithelial cells.
The Raman band at 1004 cm−1, which remained with equal




















Figure 1. (a) Raman spectra of the sliced human oral keratinized oral mucosa. The four major peaks were as follows: amide I at 1650 cm−1; CH at
1440 cm−1; broad amide III with two peaks at 1270 and 1300 cm−1; and phenylalanine at 1001 cm−1. The amide I, C–H, amide III and C–OH peaks
decreased from the 100- to 150-µm slice to the 0- to 50-µm slice as the keratinocytes matured. (b) A representative hematoxylin and eosin-stained
cross-section diagram of normal oral mucosa. Bar width: 50 µm.
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side chain bond (predominantly phenylalanine) of proteins. This
result is in agreement with previous Raman studies of connective
tissue and epithelial layer of oral mucosa.[14] The relative intensity
of the 1254 cm−1 peak in the amide III region increased when the
measuring depth went down, and a right shift of the wavelength
in the amide I region was noted from Fig. 1 as the measurement
went deeper. These results are also the same as found in the
reference cited above.[14]
Raman spectroscopy of the EVPOME on day 1, 7, 14 and 21
The Raman spectra of EVPOME (Fig. 2) showed a sharp, strong
amide I band at 1655 cm−1, a strong CH2 deformation band at
1440 cm−1, broad peaks in the amide III 1200–1350 cm−1 region,
a broad C–OH peak at 1080 cm−1 and the sharp phenylalanine
peak at 1001 cm−1, all of which resembled the Raman peaks
from normal oral mucosa shown in Fig. 1. The relative intensity
of the 1254 cm−1 peak in the amide III region decreased when
the epithelial layer thickness increased. This can be explained by
the fact that the signal from the connective tissue became smaller
because of the masking effect of increased keratinocyte layer.[14]
We also observed the largest Raman peak intensity decrease
as the EVPOME matured, except for the phenylalanine Raman
peak within the 21-day course. According to our findings, the
intensity of the anticipated peaks could be used as an indicator
for monitoring the cellular activities of the EVPOMEs. The left-
shift phenomenon of Raman spectrum in the amide I region as
the EVPOMEs got more matured also was noted. In order to
study the shifting of the Raman spectra, we placed emphasis on
the wavenumbers between 1600 and 1700 cm−1. In Fig. 3(a), the
amide I peaks were at 1652, 1659 and 1666 cm−1 at the measuring
depth of 50, 100 and 150 µm of the native oral mucosal tissue,
respectively. And the amide I peaks were at 1666, 1666, 1657 and
1651 cm−1 on day 1, 7, 14 and 21 (Fig. 3(b)). According to the
previous transmission electron microscopic study of the junction
between basal cell layer of epidermis and the connective tissue,
the anchoring fibrils were unique and abundant in this area, and
the type VII collagen was analyzed to be the major component.[15]
Therefore, we measured the Raman spectra of the pure collagen
VII from rat tail (Sigma–Aldrich, St. Louis, MO). It showed a peak at
1669 cm−1 in the amide I region (Fig. 3(c)), which can explain the
similar peaks revealed from the Raman scanning of normal oral
mucosa at 150 µm depth from the junction of epithelial cells and
the connective tissues and that of day 1 and 7 which had very thin
layers of keratinocytes covering the cadaveric connective tissue of
AlloDerm. To our best knowledge, this is the first presentation of
the Raman spectra of the pure collagen VII.
Univariate data analysis
Because of the characteristics of the phenylalanine Raman
spectra, further investigations were carried out using band area
calculations to reveal the maturation/matrix ratios of amide




















Figure 2. Raman spectra of the EVPOME. The major peaks were similar to those of the normal oral mucosa shown in Fig. 1. All the signal intensities
decreased as the cultivation date increased, except phenylalanine. The adjacent representative diagrams show the hematoxylin and eosin-stained
cross-section diagram of the EVPOME on different cultivation dates. Bar width: 50 µm.
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Figure 3. (a) Detailed amide I region plots in the Raman spectra of the sliced human oral keratinized oral mucosa between 1600 and 1700 cm−1. Right
shift of the peak was noted when the measurement went deeper. (b) Detailed amide I region plots in Raman spectra of the EVPOME between 1600 and
1700 cm−1. Left shift of the peak was noted when the cultivation day increased. (c) Raman spectra of the pure type VII collagen from rat tail. Its amide I
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Figure 4. (a) Linear regression of the amide I/phenylalanine peak ratios at different depths of normal oral mucosa. Y = −0.0432x + 3.4883; R2 = 0.8698.
(b) Linear regression of the amide I/phenylalanine peak ratio at different cultivation dates for the EVPOMEs. Y = −0.195x + 9.8015; R2 = 0.9547.
amide I/phenylalanine peak area ratio of normal oral mucosa
at different slices had a linear regression (R2 = 0.8698). This
phenomenon represented the relationship between the maturity
of the cultured oral keratinocytes and the decrease in amide
I/phenylalanine peak area ratio. A convincing linear regression
(R2 = 0.9547) of the amide I/phenylalanine peak ratio of the
EVPOMEs at different cultivating days with different maturation
stages is shown in Fig. 4(b). We did not use the statistical data
relating to the amide III and the CH2 group at 1245–1270
and 1445 cm−1, respectively, because peak interference was
encountered in the broad amide III bands and the complex
characteristics of the CH2 functional group.
The amide I band at 1645–1660 cm−1 represents an α-
helix structure in proteins, whereas the amide I band between
1665–1680 and 1660–1670 cm−1 represents theβ-sheet structure
and random coil.[16,17] In epithelial tissue, the most abundant
proteins that possess an α-helix structure are collagens,[18] and
the Raman spectrum is very sensitive to secondary structure of
the polypeptide chain in the amide I region.[19] The type VII
collagen fibril, especially, is composed of three identical alpha
collagen chains and is restricted to the basement zone beneath
stratified squamous epithelia. It functions as an anchoring fibril
between the external epithelia and the underlying stroma.[20] Our
data showed the 1669 cm−1 peak in the amide I region of pure
collagen VII, and this can explain the 1666 cm−1 peaks in the
amide I region revealed in the depth of normal oral mucosa at
150 µm from the junction of epithelial layer and the underlying
stroma and that of day 1 and 7 EVPOMEs. What about the left
shift of peaks in the amide I region detected in the depth of
normal oral mucosa of 50 and 100 µm and that of day 14 and 21
EVPOMEs? De Veld et al. and Malini et al. obtained similar results,
but no definite explanation was given.[14,21] Our collaborating
team found recently that the vascular endothelial growth factor
(VEGF), which is produced by keratinocytes and has been known
to be constitutively secreted from keratinocytes in monolayer
cultures,[22 – 24] increased in association with increasing numbers
of viable cells in the EVPOME and could be a screening marker
of the metabolic activity.[25] The secondary structure of VEGF is
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smaller than that of collagen and has more α-helical segments
than the collagen (coiled coil). We have arrived at a preliminary
conclusion regarding the peak shift noted in both normal oral
mucosa and three-dimensional EVPOME construct.
Phenylalanine is an essential amino acid that is found naturally
in the milk of mammals. Phenylalanine’s conversion into tyrosine
is catalyzed by the enzyme phenylalanine hydroxylase (PAH;
phenylalanine 4-monooxygenase, EC 1.14.16.1), which is mainly
expressed in the liver. PAH activity has also been detected in
the skin.[26] In keratinocytes, tyrosine is the substrate for tyrosine
hydroxylase, leading to the production of catecholamines.[27] The
stable peak intensity of the phenylalanine band at 1004 cm−1
could be explained by the active catalysis of phenylalanine by
viable keratinocytes grown on the EVPOME. Meanwhile, the
proteins/peptides have phenylalanine side chain, also giving rise
to the Raman peak at 1001 cm−1, and their roles in the cellular
activities are different[28,29] and therefore we could not arrive at a
conclusion in our study.
Conclusions
We have characterized a linear regression relationship during the
EVPOME maturation process by monitoring the Raman signals of
amide I and phenylalanine. A close correlation (R2 = 0.95) between
the amide I/phenylalanine ratio and the EVPOME culturing day
was established using simple linear regression statistics. The
use of Raman vibrational spectroscopy is very important to the
understanding and monitoring of oral keratinocyte maturation
during the EVPOME fabrication process. Raman spectroscopy
provides good quantitative evidence for the maturation of
the three-dimensional construct and is therefore suitable for
noninvasive, real-time monitoring in soft tissue engineering.
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